Tyra Biosciences, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Tyra Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2024.
  • Tyra Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$24M, a 13.5% decline year-over-year.
  • Tyra Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$83.7M, a 41.5% decline year-over-year.
  • Tyra Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$69.1M, a 25% decline from 2022.
  • Tyra Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$55.3M, a 110% decline from 2021.
  • Tyra Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$26.3M, a 182% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$83.7M -$24M -$2.86M -13.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$80.9M -$18.7M -$5.43M -40.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 -$75.4M -$18.2M -$6.31M -53.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-07
Q4 2023 -$69.1M -$22.8M -$9.94M -77% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 -$59.2M -$21.2M -$8.64M -69.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$50.6M -$13.3M +$1.82M +12.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$52.4M -$11.9M +$2.95M +19.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 -$55.3M -$12.9M -$2.97M -29.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 -$52.4M -$12.5M -$5.87M -88.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$46.5M -$15.1M -$9.58M -174% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-07
Q1 2022 -$36.9M -$14.8M -$10.6M -252% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-07
Q4 2021 -$26.3M -$9.93M -$6.25M -169% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$20M -$6.64M -$4.3M -184% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$15.7M -$5.51M -$3.67M -200% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-03
Q1 2021 -$12.1M -$4.21M -$2.74M -186% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-03
Q4 2020 -$9.34M -$3.69M Oct 1, 2020 Dec 31, 2020 10-Q 2021-11-03
Q3 2020 -$2.34M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$1.84M Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-03
Q1 2020 -$1.47M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.